CFO4Life Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$672K Sell
5,551
-438
-7% -$53K 0.11% 102
2025
Q1
$668K Sell
5,989
-630
-10% -$70.2K 0.11% 93
2024
Q4
$644K Buy
6,619
+379
+6% +$36.9K 0.11% 104
2024
Q3
$718K Buy
6,240
+908
+17% +$104K 0.13% 95
2024
Q2
$568K Sell
5,332
-1,074
-17% -$114K 0.11% 103
2024
Q1
$620K Sell
6,406
-609
-9% -$58.9K 0.11% 100
2023
Q4
$708K Sell
7,015
-136
-2% -$13.7K 0.14% 90
2023
Q3
$728K Buy
7,151
+886
+14% +$90.3K 0.17% 71
2023
Q2
$632K Buy
6,265
+523
+9% +$52.8K 0.14% 85
2023
Q1
$528K Sell
5,742
-679
-11% -$62.5K 0.12% 94
2022
Q4
$583K Buy
6,421
+865
+16% +$78.5K 0.12% 96
2022
Q3
$422K Buy
5,556
+83
+2% +$6.3K 0.11% 93
2022
Q2
$453K Sell
5,473
-159
-3% -$13.2K 0.11% 93
2022
Q1
$494K Sell
5,632
-196
-3% -$17.2K 0.1% 95
2021
Q4
$510K Sell
5,828
-354
-6% -$31K 0.11% 94
2021
Q3
$506K Buy
6,182
+354
+6% +$29K 0.12% 89
2021
Q2
$532K Sell
5,828
-24
-0.4% -$2.19K 0.12% 86
2021
Q1
$500K Buy
5,852
+192
+3% +$16.4K 0.12% 88
2020
Q4
$534K Hold
5,660
0.15% 74
2020
Q3
$492K Sell
5,660
-224
-4% -$19.5K 0.17% 66
2020
Q2
$514K Buy
5,884
+67
+1% +$5.85K 0.2% 55
2020
Q1
$480K Sell
5,817
-185
-3% -$15.3K 0.26% 53
2019
Q4
$568K Sell
6,002
-78
-1% -$7.38K 0.24% 61
2019
Q3
$528K Sell
6,080
-2,975
-33% -$258K 0.24% 63
2019
Q2
$827K Sell
9,055
-1,134
-11% -$104K 0.38% 44
2019
Q1
$878K Sell
10,189
-3,360
-25% -$290K 0.41% 39
2018
Q4
$1.04M Sell
13,549
-947
-7% -$72.8K 0.46% 45
2018
Q3
$1.12M Sell
14,496
-2,610
-15% -$201K 0.5% 42
2018
Q2
$1.16M Buy
+17,106
New +$1.16M 0.48% 40